Notice of Intent To Grant Exclusive License

AGENCY:

Agricultural Research Service, USDA.

ACTION:

Notice of intent.

SUMMARY:

Notice is hereby given that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to Hepalife Technologies, Inc. of Boston, Massachusetts, an exclusive license to U.S. Patent No. 5,532,156, “Hepatocyte Cell Line Derived from the Epiblast of Pig Blastocysts”, issued on July 2, 8, 1996 and to U.S. Patent No. 5,866,420, “Artificial Liver Device”, issued on February 1, 1999.

DATES:

Comments must be received within thirty (30) calendar days of the date of publication of this Notice in the Federal Register.

ADDRESSES:

Send comments to: USDA, ARS, Office of Technology Transfer, 5601 Sunnyside Avenue, Room 4-1174, Beltsville, Maryland 20705-5131.

FOR FURTHER INFORMATION CONTACT:

June Blalock of the Office of Technology Transfer at the Beltsville address given above; telephone: 301-504-5989.

SUPPLEMENTARY INFORMATION:

The Federal Government's intellectual property rights to this invention are assigned to the United States of America, as represented by the Secretary of Agriculture. It is in the public interest to so license this invention as Hepalife Technologies, Inc. of Boston, Massachusetts has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within thirty (30) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.